TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07682818: Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Hepatic Function

Sponsor: Zealand Pharma · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 36 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$3,770,192

Rescue Site Savings

+$2,483,360

Unlock Full NCT07682818 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07682818 Rescue Dossier →